🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
his is a single-center, randomized, double-blind, placebo-controlled clinic...
Status
Not Yet Recruiting
Location
Shanghai East Hospital
Start Date
2026-01-07
Trial ID
NCT07294495
Treatments Being Tested
To evaluate the safety of 18F-LNC1007 injection in the diagnosis of suspect...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-03-01
Trial ID
NCT06205888
Treatments Being Tested
This prospective, open-label Phase I/II trial evaluates a PET/CT-guided pla...
Status
Not Yet Recruiting
Location
The 960th Hospital of People's Liberation Army (PLA)
Start Date
2026-01
Trial ID
NCT07327515
PET / CT examination using \[18F\] FAPI-74 is performed on patients diagnos...
Status
Recruiting
Location
Osaka University Hospital
Start Date
2022-05-09
Trial ID
NCT05442151
Treatments Being Tested
Histiocytic disorders are rare diseases that are characterized by tissue in...
Status
Unknown
Location
Department of Nuclear Medicine, Peking Union Medical College Hopital, Chinese Academy of Medical Science
Start Date
2023-05-01
Trial ID
NCT05803629
FAPI PET has been developed as a promising approach for the evaluation of f...
Status
Recruiting
Location
Dept. of Nuclear Medicine, Peking University Third Hospital
Start Date
2023-12-15
Trial ID
NCT06359795
Treatments Being Tested
This study is a prospective cohort investigation in which consecutive eligi...
Status
Recruiting
Location
The Affiliated Hospital of Qingdao University
Start Date
2025-07-30
Trial ID
NCT07107919
Treatments Being Tested
The purpose of this study was to evaluate the diagnostic efficacy and progn...
Status
Not Yet Recruiting
Location
Pet /Ct/Mri
Start Date
2026-05-01
Trial ID
NCT07510867
The aim of the project is to demonstrate superior detection ratio of \[18F\...
Status
Recruiting
Location
University Hospital Antwerp (UZA)
Start Date
2025-02-06
Trial ID
NCT06782412
Treatments Being Tested
Evaluate the safety of the novel FAP targeted molecular probe 18F-FAPI-YQ10...
Status
Recruiting
Location
Nanjing First Hospital
Start Date
2025-04-10
Trial ID
NCT06937112
Treatments Being Tested